Company intelligence / Profile preview

Pelago Bioscience

Solna, Stockholm County, Swedenpelagobio.com ↗

Ownership: Private
Employees: ~45
Development stage: Other

Overview

Pelago Bioscience provides contract research services using its patented CETSA® technology to enable physiologically relevant assessment of drug-target engagement in live cells, tissues, and animal models. This accelerates early-stage drug discovery by providing actionable data that improves compound prioritization and reduces risk of late-stage failure. The company has established partnerships with leading pharmaceutical companies globally.

Modalities: Small molecule
Industry: Drug Discovery Services

Partnerships

Pelago has license agreements with leading big pharma companies who use the CETSA technology in-house. Specific partners are not named publicly.

Beyond the preview

Go deeper on Pelago Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pelago Bioscience.

Explore the full profile